Hyon K. Choi

65.0k total citations · 18 hit papers
405 papers, 38.3k citations indexed

About

Hyon K. Choi is a scholar working on Nephrology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Hyon K. Choi has authored 405 papers receiving a total of 38.3k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Nephrology, 157 papers in Rheumatology and 90 papers in Pathology and Forensic Medicine. Recurrent topics in Hyon K. Choi's work include Gout, Hyperuricemia, Uric Acid (194 papers), Alcohol Consumption and Health Effects (73 papers) and Liver Disease Diagnosis and Treatment (57 papers). Hyon K. Choi is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (194 papers), Alcohol Consumption and Health Effects (73 papers) and Liver Disease Diagnosis and Treatment (57 papers). Hyon K. Choi collaborates with scholars based in United States, Canada and New Zealand. Hyon K. Choi's co-authors include Gary C. Curhan, Yanyan Zhu, Bhavik J. Pandya, Earl S. Ford, Yuqing Zhang, Karen Atkinson, J. Antonio Aviña‐Zubieta, Walter C. Willett, Elizabeth W. Karlson and K. Sharan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Hyon K. Choi

392 papers receiving 36.8k citations

Hit Papers

Estimates of the prevalence of arthritis and other rheuma... 2002 2026 2010 2018 2007 2011 2008 2002 2004 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
    2007 4.4k citations Hyon K. Choi et al. profile →
  2. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
    2011 1.4k citations Yanyan Zhu, Bhavik J. Pandya et al. profile →
  3. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studies
    2008 1.1k citations J. Antonio Aviña‐Zubieta, Hyon K. Choi et al. Arthritis Care & Research profile →
  4. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
    2002 835 citations Hyon K. Choi et al. profile →
  5. Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
    2004 795 citations Hyon K. Choi, Gary C. Curhan et al. profile →
  6. Pathogenesis of Gout
    2005 724 citations Hyon K. Choi, David B. Mount et al. profile →
  7. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016
    2019 702 citations Chio Yokose, K. Sharan et al. Arthritis & Rheumatology profile →
  8. Hyperuricemia and incident hypertension: A systematic review and meta‐analysis
    2010 573 citations Seoyoung C. Kim, Hyon K. Choi et al. Arthritis Care & Research profile →
  9. Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis
    2010 516 citations Seoyoung C. Kim, James P. Guevara et al. Arthritis Care & Research profile →
  10. Alcohol intake and risk of incident gout in men: a prospective study
    2004 515 citations Hyon K. Choi, Gary C. Curhan et al. profile →
  11. Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
    2012 499 citations Yanyan Zhu, Bhavik J. Pandya et al. The American Journal of Medicine profile →
  12. Gout
    2019 455 citations Nicola Dalbeth, Hyon K. Choi et al. profile →
  13. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
    2019 409 citations Zachary S. Wallace, Hyon K. Choi et al. Annals of the Rheumatic Diseases profile →
  14. Epidemiology of Gout
    2014 360 citations Edward Roddy, Hyon K. Choi Rheumatic Disease Clinics of North America profile →
  15. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
    2014 354 citations Hyon K. Choi et al. Annals of the Rheumatic Diseases profile →
  16. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study
    2018 238 citations Kimberly G. Blumenthal, Na Lu et al. profile →
  17. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts
    2019 238 citations Zachary S. Wallace, Yuqing Zhang et al. Annals of the Rheumatic Diseases profile →
  18. Trends in Prevalence of Gout Among US Asian Adults, 2011-2018
    2023 60 citations Chio Yokose, Natalie McCormick et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyon K. Choi United States 95 16.9k 15.6k 9.0k 7.4k 6.2k 405 38.3k
Kenneth G. Saag United States 86 4.0k 0.2× 7.4k 0.5× 6.0k 0.7× 3.3k 0.4× 2.7k 0.4× 476 26.7k
Michael Doherty United Kingdom 91 6.2k 0.4× 17.6k 1.1× 11.2k 1.2× 1.8k 0.2× 1.6k 0.3× 590 33.4k
Alberto Ortíz Spain 85 9.8k 0.6× 1.8k 0.1× 3.8k 0.4× 2.6k 0.4× 3.2k 0.5× 847 28.9k
Daniel H. Solomon United States 96 1.7k 0.1× 13.5k 0.9× 7.5k 0.8× 3.0k 0.4× 4.1k 0.7× 585 36.0k
Peter Stenvinkel Sweden 98 19.6k 1.2× 1.7k 0.1× 6.5k 0.7× 1.6k 0.2× 4.4k 0.7× 648 38.2k
John P. Bilezikian United States 112 15.8k 0.9× 1.7k 0.1× 10.7k 1.2× 7.1k 1.0× 3.9k 0.6× 623 43.4k
Nicola Dalbeth New Zealand 66 11.5k 0.7× 6.2k 0.4× 5.6k 0.6× 2.2k 0.3× 1.6k 0.3× 561 17.1k
Cynthia S. Crowson United States 87 1.8k 0.1× 13.7k 0.9× 4.7k 0.5× 2.7k 0.4× 3.4k 0.5× 476 28.1k
Matthew J. Budoff United States 119 4.1k 0.2× 1.9k 0.1× 16.6k 1.8× 2.6k 0.3× 6.2k 1.0× 1.5k 60.1k
Ravi Thadhani United States 84 9.1k 0.5× 1.1k 0.1× 3.1k 0.3× 7.8k 1.0× 2.4k 0.4× 293 30.6k

Countries citing papers authored by Hyon K. Choi

Since Specialization
Citations

This map shows the geographic impact of Hyon K. Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyon K. Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyon K. Choi more than expected).

Fields of papers citing papers by Hyon K. Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyon K. Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyon K. Choi. The network helps show where Hyon K. Choi may publish in the future.

Co-authorship network of co-authors of Hyon K. Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Hyon K. Choi. A scholar is included among the top collaborators of Hyon K. Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyon K. Choi. Hyon K. Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saag, Kenneth G., Nicola Dalbeth, Chang‐Fu Kuo, et al.. (2025). Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies. Contemporary Clinical Trials. 151. 107843–107843.
2.
Mandal, Asim K., Tony R. Merriman, Hyon K. Choi, & David B. Mount. (2024). Caffeine Inhibits Both Basal and Insulin‐Activated Urate Transport. Arthritis & Rheumatology. 76(11). 1658–1669. 3 indexed citations
3.
4.
5.
Lin, Kueiyu Joshua, et al.. (2023). POS0368 PERSISTENT PREMATURE MORTALITY IN GOUT: NATIONWIDE PROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 82. 436–436. 1 indexed citations
6.
Choi, Hyon K., et al.. (2023). Comparative Risks of Infection With Belimumab Versus Oral Immunosuppressants in Patients With Nonrenal Systemic Lupus Erythematosus. Arthritis & Rheumatology. 75(11). 1994–2002. 13 indexed citations
7.
Wei, Jie, Hyon K. Choi, Nicola Dalbeth, et al.. (2023). Lowering Serum Urate With Urate‐Lowering Therapy to Target and Incident Fracture Among People With Gout. Arthritis & Rheumatology. 75(8). 1456–1465. 6 indexed citations
8.
Jorge, April, Xiaoqing Fu, Claire Cook, et al.. (2021). Kidney Transplantation and Cardiovascular Events Among Patients With End‐Stage Renal Disease Due to Lupus Nephritis: A Nationwide Cohort Study. Arthritis Care & Research. 74(11). 1829–1834. 5 indexed citations
9.
Jorge, April, Natalie McCormick, Na Lu, et al.. (2020). Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population. Arthritis Care & Research. 73(8). 1219–1223. 28 indexed citations
10.
D’Silva, Kristin M., April Jorge, A. N. Cohen, et al.. (2020). COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study. Arthritis & Rheumatology. 73(6). 914–920. 93 indexed citations
11.
Zeng, Chao, Nancy E. Lane, David J. Hunter, et al.. (2019). Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative. Osteoarthritis and Cartilage. 27(6). 855–862. 140 indexed citations
12.
Jordan, Daniel M., Hyon K. Choi, Marie Verbanck, et al.. (2019). No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study. PLoS Medicine. 16(1). e1002725–e1002725. 93 indexed citations
13.
Keller, Sarah, Na Lu, Kimberly G. Blumenthal, et al.. (2018). Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Annals of the Rheumatic Diseases. 77(8). 1187–1193. 40 indexed citations
14.
Wallace, Zachary S., Rachel Wallwork, Yuqing Zhang, et al.. (2018). Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Annals of the Rheumatic Diseases. 77(9). 1333–1338. 20 indexed citations
15.
Roddy, Edward & Hyon K. Choi. (2014). Epidemiology of Gout. Rheumatic Disease Clinics of North America. 40(2). 155–175. 360 indexed citations breakdown →
16.
Zhu, Yanyan, Bhavik J. Pandya, & Hyon K. Choi. (2012). Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008. The American Journal of Medicine. 125(7). 679–687.e1. 499 indexed citations breakdown →
17.
Kim, Seoyoung C., James P. Guevara, Kyoung Mi Kim, et al.. (2009). Hyperuricemia and risk of stroke: A systematic review and meta‐analysis. Arthritis Care & Research. 61(7). 885–892. 360 indexed citations
18.
Li, Chao, et al.. (2008). Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115. Clinical Journal of the American Society of Nephrology. 3(2). 317–323. 18 indexed citations
19.
Choi, Hyon K. & Gary C. Curhan. (2007). Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease. Circulation. 116(8). 894–900. 494 indexed citations
20.
Jick, Susan S., et al.. (2006). Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Care & Research. 55(1). 19–26. 330 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth G. Saag Breakdown of academic impact, for papers by Michael Doherty Breakdown of academic impact, for papers by Alberto Ortíz Breakdown of academic impact, for papers by Daniel H. Solomon Breakdown of academic impact, for papers by Peter Stenvinkel Breakdown of academic impact, for papers by John P. Bilezikian Breakdown of academic impact, for papers by Nicola Dalbeth Breakdown of academic impact, for papers by Cynthia S. Crowson Breakdown of academic impact, for papers by Matthew J. Budoff Breakdown of academic impact, for papers by Ravi Thadhani
Rankless by CCL
2026